Cargando…

Safety and Efficacy of Zonisamide in Patients with Epilepsy: A Post-Marketing Surveillance Study

BACKGROUND AND PURPOSE: Zonisamide (ZNS) is one of new antiepileptic drug, which is known to inhibit seizure through multiple mechanisms of action. In Korea, ZNS was approved as an antiepileptic drug in 1992 and has been used for epilepsy patients with partial and generalized seizures. The objective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hye Jin, Son, Jeong Min, Mun, Jihee, Kim, Dong Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Epilepsy Society 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724857/ https://www.ncbi.nlm.nih.gov/pubmed/26819941 http://dx.doi.org/10.14581/jer.15015

Ejemplares similares

Long-Term Efficacy and Safety of Zonisamide Monotherapy in Epilepsy Patients
por: Park, Sung-Pa, et al.
Publicado: (2007)

Efficacy of Zonisamide in Migraineurs with Nonresponse to Topiramate
por: Chung, Jin-Young, et al.
Publicado: (2014)

Zonisamide in the management of epilepsy in the elderly
por: Romigi, Andrea, et al.
Publicado: (2015)

Zonisamide Efficacy as Adjunctive Therapy in Children With Refractory Epilepsy
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2013)

Zonisamide Changes Unilateral Cortical Excitability in Focal Epilepsy Patients
por: Joo, Eun Yeon, et al.
Publicado: (2010)

Comparative Efficacy of Zonisamide and Pregabalin as an Adjunctive Therapy in Children with Refractory Epilepsy
por: TAGHDIRI, Mohammad Mahdi, et al.
Publicado: (2015)

Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature
por: Zaccara, Gaetano, et al.
Publicado: (2009)

Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
por: Ahn, Seo-Yeon, et al.
Publicado: (2022)

Zonisamide‐responsive myoclonus in SEMA6B‐associated progressive myoclonic epilepsy
por: Herzog, Rebecca, et al.
Publicado: (2021)

Limited efficacy of zonisamide in the treatment of refractory infantile spasms
por: Hussain, Shaun A., et al.
Publicado: (2020)

Efficacy, Safety, and Durability of Brolucizumab: An 8-Month Post-Marketing Surveillance Analysis
por: Saba, Nicholas J, et al.
Publicado: (2023)

Safety and efficacy of fimasartan with essential hypertension patients in real world clinical practice: data from a post marketing surveillance in Korea
por: Han, Su-Eun, et al.
Publicado: (2018)

Post-marketing safety surveillance of the rotavirus vaccine in India
por: Kang, Gagandeep, et al.
Publicado: (2023)

Zonisamide's Efficacy and Safety on Parkinson's Disease and Dementia with Lewy Bodies: A Meta-Analysis and Systematic Review
por: Kong, Linghui, et al.
Publicado: (2022)

Zonisamide Therapy Reduces Metabolic Consequences and Diminishes Nonalcoholic Fatty Liver Disease in Patients with Epilepsy
por: Huang, Chi-Ren, et al.
Publicado: (2021)

Distal renal tubular acidosis and lethargy associated with zonisamide treatment in a dog with idiopathic epilepsy
por: Itoi, Takamasa, et al.
Publicado: (2022)

Evaluation of antiseizure medications including zonisamide in feline idiopathic epilepsy at a referral hospital in Japan
por: Yoshida, Shino, et al.
Publicado: (2023)

Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017–2021)
por: Eun, Byung-Wook, et al.
Publicado: (2023)

Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients
por: Chung, Man Pyo, et al.
Publicado: (2020)

Safety of Tacrolimus in Autoimmune Disease: Results From Post-marketing Surveillance in South Korea
por: Yoo, Wan-Hee, et al.
Publicado: (2021)

Open Label Trial of the Tolerability and Efficacy of Zonisamide in the Treatment of Alcohol Dependence
por: Knapp, Clifford M., et al.
Publicado: (2010)

Zonisamide, Topiramate, and Levetiracetam: Efficacy and Neuropsychological Effects in Alcohol Use Disorders
por: Knapp, Clifford M., et al.
Publicado: (2015)

Comparative whole transcriptome analysis of Parkinson’s disease focusing on the efficacy of zonisamide
por: Naito, Tatsuhiko, et al.
Publicado: (2022)

Efficacy and safety of ibrutinib in relapsed/refractory CLL and SLL in Japan: a post-marketing surveillance
por: Omi, Ai, et al.
Publicado: (2022)

Impact of Pregnancy on Zonisamide Pharmacokinetics in Rabbits
por: Matar, Kamal M.
Publicado: (2013)

Repositioning again of zonisamide for nerve regeneration
por: Ohno, Kinji, et al.
Publicado: (2016)

Zonisamide-induced acute kidney injury
por: Dixit, Deepali, et al.
Publicado: (2015)

Zonisamide-Induced Hallucinations: An Anticonvulsant’s Psychosis
por: Al Armashi, Abdul Rahman, et al.
Publicado: (2021)

Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China
por: Meng, Fan-Ya, et al.
Publicado: (2017)

Comparing Zonisamide With Sodium Valproate in the Management of Migraine Headaches: Double-Blind Randomized Clinical Trial of Efficacy and Safety
por: Assarzadegan, Farhad, et al.
Publicado: (2016)

Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
por: Kim, Hyeongyeong, et al.
Publicado: (2021)

Cognitive Profile of Zonisamide and Valproic Acid in the Treatment of Idiopathic Generalized Epilepsy: A Comparative Observational Study
por: Ramirez-García, Teresa, et al.
Publicado: (2016)

Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
por: Li, Chunxiao, et al.
Publicado: (2018)

Efficacy and Safety of Zonisamide in Dementia with Lewy Bodies Patients with Parkinsonism: A Post Hoc Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials
por: Hasegawa, Kazuko, et al.
Publicado: (2021)

Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance
por: Moon, Jun Sung, et al.
Publicado: (2023)

Real-World Safety and Efficacy of Glycopyrronium Bromide in Japanese Patients with COPD: A 52-Week Post-Marketing Surveillance
por: Kato, Chihiro, et al.
Publicado: (2022)

Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data
por: Yoo, Wan-Hee, et al.
Publicado: (2022)

Zonisamide is effective in the preventive therapy of chronic migraine
por: Belvis, R, et al.
Publicado: (2013)

Probable drug-induced lupus erythematosus by zonisamide
por: Safadi, Mohannad G., et al.
Publicado: (2021)

Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
por: Jeon, Hee Jung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7bvrmar326v876cfsde7e1831q